Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases.

Saved in:
Bibliographic Details
Title: Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases.
Authors: Wang T; Department of Cancer Chemistry, AstraZeneca R&D Boston, Waltham, Massachusetts 02451, USA. tao.wang@astrazeneca.com, Lamb ML, Scott DA, Wang H, Block MH, Lyne PD, Lee JW, Davies AM, Zhang HJ, Zhu Y, Gu F, Han Y, Wang B, Mohr PJ, Kaus RJ, Josey JA, Hoffmann E, Thress K, Macintyre T, Wang H, Omer CA, Yu D
Source: Journal of medicinal chemistry [J Med Chem] 2008 Aug 14; Vol. 51 (15), pp. 4672-84. Date of Electronic Publication: 2008 Jul 23.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first